In this modern age, it’s remarkable that after more than a half-century survival from cardiac arrest have shown minimal improvement. However, in some cutting-edge cities, survival rates exceed the national average, leading us to reevaluate what is necessary to improve outcomes. From adopting new technologies that enhance blood flow in the pre-hospital setting, to implementing resuscitative protocols, including extracorporeal membrane oxygenation (ECMO), we must be open to new ideas when tackling cardiac arrest. To make progress in a field that has been seemingly stagnate, progressive programs may finally move the needle on survival rates while also creating best practices for future resuscitation initiatives.
Please join us for this event sponsored by ZOLL Medical.
Sponsored By ZOLL Medical
ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.
Visit us at www.zoll.com for more information.